Edwards Lifesciences Corp. (EW) Tops Q4 EPS by 13c; Guides Q1, FY13

February 4, 2013 4:02 PM

Edwards Lifesciences Corp. (NYSE: EW) reported Q4 EPS of $0.90, $0.13 better than the analyst estimate of $0.77. Revenue for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found